With your help, we can help advance medical knowledge and improve the health and well-being of countless others.

〉
Available Studies

〉
Frequently Asked Questions

〉
Volunteer Form

Our goal is to assist the pharmaceutical and medical device industries develop new and effective products to treat a multitude of medical conditions and illnesses. We perform this important work through the administration of clinical trials.

Please consider joining us in this effort. Our experienced and professional clinical research staff are highly qualified and fully committed to engaging you and your primary care physician as informed partners in everything we do.

Available Studies

See if you pre-qualify for any of the research studies we are now conducting in your area by following one of the links below.

Investigational COVID-19 Oral Tablet Vaccine Trial

AMR Ft. Myers is conducting an investigational study for a COVID-19 oral tablet vaccine trial for healthy participants ages 18 and older who have completed their primary mRNA COVID-19 series.

 

Qualified participants must:

  • have received 2 or more mRNA shots against COVID-19, such as Moderna or Pfizer.
  • have had their last COVID-19 shot at least 6 months before taking part in the study
  • meet other study criteria

Qualified participants will receive all study-related care at no cost.  Reimbursement is available up to $770.00 for study-related time and travel.

By participating in this investigational study, you’ll have the opportunity to contribute to the ongoing efforts in the fight against COVID-19. Your involvement could potentially help advance the development of an oral tablet vaccine, which would be a significant step forward in combatting this global health crisis.

If you are interested in learning more, call AMR today at 888-259-1231 or fill out the form below and a member of our recruitment team will contact you to get started.

Healthy Volunteer Study

Clinical Study Center is growing its database of healthy volunteers who might be candidates for future studies which will be starting over the next twelve months.

Obesity Clinical Research Study

AMR Ft. Myers is conducting a Clinical Trial of an Investigational Once-Daily ORAL Medication for Type 2 Diabetics with Cardiovascular Risk.

Qualified participants:

· Are 18 and Older
· Have either Heart Disease (incl. heart attack, stent, bypass surgery, heart failure, among others), Peripheral Artery Disease, Kidney Disease, or have had a Stroke or TIA

AND

· Have an A1C of 7 to 10.5 (Stable Treatment of One to Three Oral Medications for Diabetes) Note: If Taking Metformin, ≥1500 mg/day is required.
· Meet Other Study Requirements (Use of Insulin and/or Some Newer Injectable Diabetic Medications is Prohibited)

Reimbursement is available for time and travel.
Contact AMR Ft. Myers at 888-259-1231.

Investigational Cardiovascular Disease Clinical Study

Cardiovascular disease is risky business! That’s why AMR Ft. Myers is conducting a clinical trial of an investigational medication to potentially reduce major adverse cardiovascular events in those with a previous history of adverse cardiovascular events and in those who are at high cardiovascular risk.

Qualified participants must:

· be ages 18 and older with a history of a major cardiovascular event Or
· be ages 50 and older who are at high risk for having their first major cardiovascular event
· meet other study criteria

Qualified participants will receive:

· all study-related care and the investigational medication or placebo at no cost
· compensation up to $2,550.00 for time and travel

Learn more by calling AMR Ft. Myers at 888-259-1231 today!

Clinical Study of an Investigational Obesity Drug and Its Heart Safety

AMR Ft. Myers is conducting a study to test an investigational drug on cardiovascular safety for people who are overweight or obese.

Qualified participants must:

· be ages 18 and older
· have a BMI of 27 or greater
· have cardiovascular disease, chronic kidney disease, or at least two risk factors for cardiovascular disease such as hypertension, dyslipidemia, Type 2 Diabetes, or Non-alcoholic steatohepatitis (NASH)
· meet other study criteria

Qualified participants will receive at no cost:

· all study-related care
· the investigational drug or placebo

Compensation for time and travel may be provided.
Learn more by calling AMR Ft. Myers at 888-259-1231 today!

Clinical Research Trial of an Investigational Atopic Dermatitis Vaccine

AMR is conducting a clinical research trial of an investigational Atopic Dermatitis (AD) vaccine. Qualified participants must be 18 and older with a diagnosis of AD for at least one year.

Qualified participants must:

· be 18 and older
· be diagnosed with moderate to severe Atopic Dermatitis (AD) for at least one year
· have had inadequate response to topical treatments for at least six months
· meet other study criteria

Receive all trial-related care and investigational vaccine or placebo at no cost. Compensation is available for time and travel up to $700.00.
To learn more, contact AMR at 888-259-1231 today.

Clinical Research Study for Participants with COPD

AMR is currently accepting volunteers to participate in a COPD clinical research study.  Qualified participants are those ages 40 to 80 who meet other study criteria.  Qualified participants will receive all study-related care and the investigational medication or placebo at no cost.  Compensation may be available for study-related time and travel. To learn more, call AMR at 888-259-1231 today!

Healthy Volunteer Clinical Research Study

AMR Ft. Myers is currently seeking healthy volunteers to participate in a clinical research study of an investigational medication to prevent Botulism.
Qualified participants must:
• be a healthy adult 18 to 65 years of age
• meet other study criteria

Qualified participants will receive at no cost:
• all study-related medical exams
• lab tests
• injection of the investigational medication or placebo

Reimbursement for time and study-related travel is available up to $2,450.00. Insurance is not required.

To see if you qualify, call:
AMR Ft. Myers at 888-259-1231

Influzena Vaccine Clinical Research Study

AMR would like to invite you to participate in an Influenza Vaccine clinical research study happening now.

Qualified participants must:
• be 50 to 64 years of age
• meet additional study criteria

Receive all study-related care and the study vaccine at no cost. Compensation may be available for time and travel.

To learn more, call AMR at 888-259-1231.

Respiratory Syncytial Virus (RSV) Booster Vaccine Study

Did you receive an AREXVY vaccine 1.5 years ago? If yes, participate in a RSV booster vaccine study with AMR Ft. Myers today! Study compensation for your time and travel up to $795 is available for qualified participants. Qualified participants must be 60 to 85, have received no more than one dose of AREXVY at least 1.5 years before study enrollment, and meet other study criteria

If you are interested in learning more, call AMR today at 888-259-1231 or fill out the form below and a member of our recruitment team will contact you to get started.

Investigational Atopic Dermatitis Trial

AMR Ft. Myers is currently enrolling participants in a chronic spontaneous urticaria (chronic hives) clinical research trial for those 18 and older. Qualified participants must have a confirmed diagnosis of chronic spontaneous urticaria, not have a history of other diseases with hives or swelling symptoms, and meet other study criteria. Qualified participants will receive all study-related care at no cost. Compensation is available up to $1,500.00 for study-related time and travel.
If you are interested in learning more, call AMR today at 888-259-1231 or fill out the form below and a member of our recruitment team will contact you to get started.

Investigational Alopecia Areata Trial

AMR Ft. Myers is conducting a clinical research study for adolescents 12 to 17 and adults 18 and older with a diagnosis of alopecia areata. Qualified participants must be experiencing hair loss that began within the last 10 years and meet other study criteria to participate. Receive all study-related care and the investigational treatment at no cost. Compensation for study-related costs is available up to $1,350.00.
If you are interested in learning more, call AMR today at 888-259-1231 or fill out the form below and a member of our recruitment team will contact you to get started.

Investigational Plaque Psoriasis Research Study

AMR Ft. Myers is conducting a clinical research study for those 18 and older with moderate to severe plaque psoriasis who are overweight or obese. Qualified participants must have a diagnosis of moderate to severe plaque psoriasis, have a BMI of 30 or greater or 27 to less than 30 with at least 1 weight-related condition (hypertension, high cholesterol, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease), have initiated treatment with ixekizumab for 2 to 4 months, and meet other study criteria to participate. Qualified participants will receive all study-related care for 12 months at no cost. Compensation may be available for study-related time.

If you are interested in learning more, call AMR today at 888-259-1231 or fill out the form below and a member of our recruitment team will contact you to get started.

Investigational Weight Management Study

AMR-Clinical Ft. Myers is seeking participants 18 or older who are obese or overweight for a weight loss study. Qualified participants must have a BMI of 30 or higher or have a BMI 27 or higher with one medical condition such as high blood pressure, high cholesterol, sleep apnea, or heart disease, must not have Type 2 diabetes and meet other study criteria. Qualified participants will receive all study-related care at no cost. Compensation is available up to $7,700.00 for study-related time and travel.

If you are interested in learning more, call AMR-Clinical today at 888-259-1231 or fill out the form below and a member of our recruitment team will contact you to get started.

Frequently Asked Questions

Clinical trials are conducted in phases. The trials at each phase have a different purpose and help scientists answer different questions:

In Phase I trials, researchers test an experimental drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

In Phase II trials, the experimental study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.

In Phase III trials, the experimental study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the experimental drug or treatment to be used safely.

A protocol is a study plan on which all clinical trials are based. The plan is carefully designed to safeguard the health of the participants as well as answer specific research questions. A protocol describes what types of people may participate in the trial; the schedule of tests, procedures, medications, and dosages; and the length of the study. While in a clinical trial, participants following a protocol are seen regularly by the research staff to monitor their health and to determine the safety and effectiveness of their treatment.

Clinical trials are sponsored or funded by a variety of organizations or individuals such as physicians, medical institutions, foundations, voluntary groups, and pharmaceutical companies, in addition to federal agencies such as the National Institutes of Health (NIH), the Department of Defense (DOD), and the Department of Veterans Affairs (VA). Trials can take place in a variety of locations, such as hospitals, universities, doctors’ offices, or community clinics.

The ethical and legal codes that govern medical practice also apply to clinical trials. In addition, most clinical research is federally regulated with built-in safeguards to protect the participants. The trial follows a carefully controlled protocol, a study plan which details what researchers will do in the study. As a clinical trial progresses, researchers report the results of the trial at scientific meetings, to medical journals, and to various government agencies. Individual participants’ names will remain secret and will not be mentioned in these reports.

Benefits

Clinical trials that are well-designed and well-executed are the best approach for eligible participants to:

Play an active role in their own health care.
Gain access to new research treatments before they are widely available.
Obtain expert medical care at leading healthcare facilities during the trial.
Help others by contributing to medical research.
Risks

There are risks to clinical trials.

There may be unpleasant, serious or even life-threatening side effects to experimental treatment.
The experimental treatment may not be effective for the participant.
The protocol may require more of their time and attention than would a non-protocol treatment, including trips to the study site, more treatments, hospital stays or complex dosage requirements.

Informed consent is the process of learning the key facts about a clinical trial before deciding whether or not to participate. It is also a continuing process throughout the study to provide information for participants. To help someone decide whether or not to participate, the doctors and nurses involved in the trial explain the details of the study. If the participant’s native language is not English, translation assistance can be provided. Then the research team provides an informed consent document that includes details about the study, such as its purpose, duration, required procedures, and key contacts. Risks and potential benefits are explained in the informed consent document. The participant then decides whether or not to sign the document. Informed consent is not a contract, and the participant may withdraw from the trial at any time.

The clinical trial process depends on the kind of trial being conducted (See What are the different types of clinical trials?) The clinical trial team includes doctors and nurses as well as social workers and other healthcare professionals. They check the health of the participant at the beginning of the trial, give specific instructions for participating in the trial, monitor the participant carefully during the trial, and stay in touch after the trial is completed.

Some clinical trials involve more tests and doctor visits than the participant would normally have for an illness or condition. For all types of trials, the participant works with a research team. Clinical trial participation is most successful when the protocol is carefully followed and there is frequent contact with the research staff.

All clinical trials have guidelines about who can participate. Using inclusion/exclusion criteria is an important principle of medical research that helps to produce reliable results. The factors that allow someone to participate in a clinical trial are called “inclusion criteria” and those that disallow someone from participating are called “exclusion criteria”. These criteria are based on such factors as age, gender, the type and stage of a disease, previous treatment history, and other medical conditions. Before joining a clinical trial, a participant must qualify for the study. Some research studies seek participants with illnesses or conditions to be studied in the clinical trial, while others need healthy participants. It is important to note that inclusion and exclusion criteria are not used to reject people personally. Instead, the criteria are used to identify appropriate participants and keep them safe. The criteria help ensure that researchers will be able to answer the questions they plan to study

Participants in clinical trials can play a more active role in their own health care, gain access to new research treatments before they are widely available, and help others by contributing to medical research.

Although there are many definitions of clinical trials, they are generally considered to be biomedical or health-related research studies in human beings that follow a predefined protocol. ClinicalTrials.gov includes both interventional and observational types of studies. Interventional studies are those in which the research subjects are assigned by the investigator to a treatment or other intervention, and their outcomes are measured. Observational studies are those in which individuals are observed and their outcomes are measured by the investigators.

Volunteer Form

To participate in studies, fill out the form below to volunteer. We will contact you within 48 hours to verify your eligibility and clarify any questions you may have.

By volunteering for clinical studies, you authorize AMR to store your personal information on file. In accordance with HIPAA regulations, AMR will never share your information with anyone.

Name(Required)

Address(Required)

Ex. Facebook, Instagram, TikTok, Amazon, TV, Radio, Flyer, Word of Mouth.


Consent(Required)
SMS Consent(Required)
This field is for validation purposes and should be left unchanged.

Respiratory Syncytial Virus

It is estimated that more than 177,000 older adults are hospitalized and 14,000 of them die in the US due to RSV infections per year. In 2018, more elder Americans died from RSV infection than the common flu.

AMR locations nationwide are currently enrolling in investigational Adult RSV vaccine clinical research studies. Respiratory Syncytial Virus – or RSV – is most commonly discussed in children ages newborn to four. However, RSV, much like the flu or coronavirus, can cause long-term damage to the lungs. It can be life-threatening for adults 60 years and older and for those with compromised health conditions.
To learn more, call our enrollment line:

Refer-A-Friend

Earn extra cash* by recommending a friend to us and receive up to $100 for each friend you refer!

The thousands of participants who have volunteered for clinical research studies with us have enabled us to play an important role in the advancement of medicine. This would not be possible without the help of our study volunteers. Thank you for partnering with us as we work together to improve the quality of life in our community. That said, we are always in need of additional study participants and are grateful when a friend or family member is recommended to us. As a thank-you for helping us, we are offering up to $100 for each eligible friend you refer to us.

Read Important Instructions

* Some restrictions apply. Not all studies are eligible for the Refer-A-Friend program. Ask an AMR representative for details.